Alex Khoruts is most interested in translating basic scientific discoveries and ideas into clinical applications. His main focus since mid-2000s has been on development of treatments to repair antibiotic injury to intestinal microbial communities, also known as the “microbiota.” His lab has developed therapeutic preparations of donor microbiota to treat patients with difficult C. difficile infections, commonly known as Fecal Microbiota Transplants (FMT) or Intestinal Microbiota Transplants (IMT). Alex’s research program is committed to support academic trials for a variety of applications in the areas of ulcerative colitis, autism, advanced liver disease, and others.